Fiche centre
Luoyang Third People's Hospital
Luoyang — China
Essais liés6clinical trials
VilleLuoyanglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06424288
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Low dose QiShen YiQi Dripping Pills 3 bags | Insuffisance cardiaque | Phase 2 | NCT04983043 | Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure | COMPLETED |
| Qishen Yiqi Dripping Pills 2 bags | Insuffisance cardiaque | Phase 3 | NCT07687186 | Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre | RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Vicadrostat | Insuffisance cardiaque | Phase 3 | NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | RECRUITING |
| Recombinant Human Serum Albumin | Alzheimer | Phase 1 | NCT06489015 | Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial | COMPLETED |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |